Stay updated on Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page's revision label changes from v3.6.5 to v3.6.6, signaling a new revision of the page content or metadata.
    Difference
    0.0%
    Check dated 2026-09-01T19:45:11.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.4 to v3.6.5, signaling a new build of the page content. This is a minor update to the site's documentation/template with no user-visible changes to the study details.
    Difference
    0.0%
    Check dated 2026-08-11T18:54:03.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4, indicating a small site update. No study content or functionality changes are indicated.
    Difference
    0.0%
    Check dated 2026-07-21T12:49:31.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Results Submitted has been added, replacing No Results Posted, indicating that study results are now submitted. The page revision was updated from v3.6.0 to v3.6.3.
    Difference
    0.1%
    Check dated 2026-06-30T02:03:32.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    New recruitment status text 'No longer looking for participants' appears on the page, clarifying enrollment status. The page also adds multiple help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment label, while the older 'Intervention / Treatment' label and 'Revision: v3.5.5' note were removed in favor of a new 'Revision: v3.6.0' note.
    Difference
    0.3%
    Check dated 2026-06-15T20:46:27.000Z thumbnail image
  9. Check
    96 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.4 to v3.5.5, indicating a new build deployment. This appears to be a behind-the-scenes update rather than a modification of the trial information.
    Difference
    0.0%
    Check dated 2026-06-08T17:09:19.000Z thumbnail image

Stay in the know with updates to Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brentuximab & Nivolumab for Early Hodgkin Lymphoma Clinical Trial page.